Medifast, Inc. (MED) Stock

Medifast, Inc. (MED) is a Consumer Staples stock trading at $11.97 (as of 2026-08-21), with a market capitalization of $133.83M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Medifast, Inc. manufactures and distributes weight loss, weight management, and other consumable health and nutritional products in the United States and Asia-Pacific. Its offerings include bars, snacks, cereals, drinks, and meal-related items sold under brands such as OPTAVIA and Optimal Health by Take Shape for Life.

Understand Medifast, Inc.: how it makes money

Medifast manufactures and sells weight-loss and healthy living consumable nutrition products under brands including OPTAVIA, and it monetizes product sales through point-of-sale transactions on an ecommerce platform supported by its Optavia coach network.

The profit model is structurally driven by the coach and client engine, since independent active earning coaches support a large client base and those clients place consumable orders across Optavia branded products, with demand partly reflected in operating metrics tied to GLP-1 participation and product mix.

Business quality (Weak): Strong transparency on operating engagement metrics (coach count, client support, GLP-1 participation, and product mix), but the provided data does not include a clean, reportable segment breakdown.

Bull case

High gross margin: Gross margin is reported at 68.1%, indicating relatively strong product economics in the latest period provided.
Brand concentration in consumables: Optavia branded products represent 88.9% of consumable units sold, which can help reinforce brand-driven demand.
Coach network supports GLP-1 clients: Operating metrics show active coaches supporting GLP-1 clients (Active Coaches Supporting at Least One GLP-1 Client: 10,000, and related coach-level GLP-1 support at 61%).

Bear case

Loss-making at the operating level: Operating margin is -4.3% in the latest period provided, meaning core operations are not yet converting revenue into operating profit.
Demand mix and adoption are linked to GLP-1 dynamics: GLP-1 participation is visible across multiple operating metrics (for example, 22% of the client base has used or tried GLP-1 medications in the past year), which could make results sensitive to changes in GLP-1 adoption or patient behavior.
Order mix depends on specific product lines: A newer product line is reflected in order mix, with Percentage of Customer Orders Including Optavia Ascend Products at 17% (January following launch), implying some dependency on product attachment over time.

Valuation — source: SEC EDGAR (first-party)
Price	$11.97
Market Cap	$133.83M
EV / EBITDA	6.4
Price / Book	0.68
Price / Sales	0.42
FCF Yield	4.6%
DCF Value (model)	$120.15
DCF Upside vs Price	903.8%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$385.79M
Net Margin	-4.8%
Revenue Growth (YoY)	-36.0%
EPS Growth (YoY)	-994.7%
FCF Growth (YoY)	-92.7%

Financial Health — source: SEC EDGAR
Altman Z-Score	4.64 (safe)

Valuation vs Sector & Industry
Sector P/E (Consumer Staples)	26.7
Industry P/E (Food Products)	26.1

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	BlackRock Fund Advisors ($36.63M)
Institutional Holders Tracked	10

Company
Sector	Consumer Staples
Industry	Food Products
CEO	Daniel R. Chard
Employees	504
Country	US
IPO Date	1993-12-30

Related Companies (Business model: Branded Consumer (CPG, Staples, Beauty, Alcohol, Pet, Nicotine); 8 closest by market cap; US-domiciled)

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.